Ishihara Chemical (TSE:4462) Margins Reach 10.6%, Bolstering Bulls on Quality and Valuation Gap
Ishihara Chemical (TSE:4462) delivered a steady year with net profit margins improving to 10.6%, edging out last year's 10.1%. EPS recorded year-over-year growth of 6.9%, though this undershot the company's strong five-year average of 9.9% annual earnings growth. Historically, earnings have increased by 9.9% per year. With the stock trading at a P/E of 12.2x, the market is seeing a notable valuation gap given the current price of ¥2,180 compared to an estimated fair value of ¥4,976.28.
See our full analysis for Ishihara Chemical.The next section puts these headline results side-by-side with the latest narratives in the market, highlighting where the numbers reinforce popular views and where they might offer a reality check.
Curious how numbers become stories that shape markets? Explore Community Narratives
High Quality Profits Sustain at 10.6% Margins
- Net profit margins came in at 10.6%, up from last year’s 10.1%. This outperformed many Japanese chemical peers.
- Margin expansion significantly supports the case that Ishihara’s earnings quality is more resilient than short-term results alone might suggest.
- With five-year average earnings growth at 9.9% annually, the company’s profitability is shown not just in one-off results but across cycles.
- Sustained margins, even in a choppy sector environment, point to durable business fundamentals and operational discipline.
Growth Trails Historical Pace Despite Profit Strength
- Earnings grew 6.9% this year, noticeably lower than the company’s robust five-year annual average of 9.9%.
- While annual growth remains positive, the dip from the average points to slower momentum even as profits remain strong.
- The relative deceleration, along with continued margin gains, raises the question of whether growth can return to previous highs.
- Still, the track record of almost 10% annualized growth shows the business has not dropped off dramatically, lending support to confidence in the underlying model.
Discounted Share Price Versus DCF Fair Value
- Shares currently trade at ¥2,180, well below the DCF fair value estimate of ¥4,976.28, and at a P/E of 12.2x compared to industry and peer group averages of 13x and 29.6x, respectively.
- The wide discount to calculated fair value contributes to the view that the stock may offer upside potential for value-focused investors.
- Compared to sector peers, the company’s lower valuation multiple comes despite steady historical profitability and minimal flagged risks.
- The absence of material risk disclosures alongside this valuation gap suggests market skepticism may not be based on fundamentals.
Curious how numbers become stories that shape markets? Explore Community NarrativesCurious how numbers become stories that shape markets? Explore Community Narratives
Next Steps
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Ishihara Chemical's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
See What Else Is Out There
While Ishihara Chemical has delivered stable profits, its earnings growth has slowed meaningfully compared to its own strong five-year average.
If consistent, reliable performance is your priority, use our stable growth stocks screener (2103 results) to target companies posting steady expansion year after year, without sacrificing quality or momentum.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Ishihara Chemical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com